Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$536M |
| 2 |
Apple
AAPL
|
+$362M |
| 3 |
Micron Technology
MU
|
+$270M |
| 4 |
Eli Lilly
LLY
|
+$228M |
| 5 |
Cisco
CSCO
|
+$179M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
Tesla
TSLA
|
+$463M |
| 3 |
NVIDIA
NVDA
|
+$424M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Meta Platforms (Facebook)
META
|
+$228M |
Sector Composition
| 1 | Technology | 19.7% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Industrials | 9.61% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
SmartFinancial
SMBK
$627M
| $4.06M | 0.01% |
139,274
-1,000
| -0.7% | -$29.1K |
|
1577
Inogen
INGN
$231M
| $4.05M | 0.01% |
417,900
+63,300
| +18% | +$614K |
|
1578
iShares Gold Trust Micro
IAUM
$3.74B
| $4.05M | 0.01% |
+154,300
| New | +$4.05M |
|
1579
Atea Pharmaceuticals
AVIR
$249M
| $4.04M | 0.01% |
1,207,100
+65,600
| +6% | +$220K |
|
1580
Viant Technology
DSP
$158M
| $4.04M | 0.01% |
364,800
-38,500
| -10% | -$426K |
|
1581
The Greenbrier Companies
GBX
$1.42B
| $4.04M | 0.01% |
+79,300
| New | +$4.04M |
|
1582
John Wiley & Sons Class A
WLY
$2.19B
| $4.01M | 0.01% |
83,100
-27,800
| -25% | -$1.34M |
|
|
LX
1583
LexinFintech Holdings
LX
$961M
| $4M | 0.01% |
1,470,400
+448,700
| +44% | +$1.22M |
|
1584
Terns Pharmaceuticals
TERN
$633M
| $4M | 0.01% |
479,500
+392,000
| +448% | +$3.27M |
|
1585
Nkarta
NKTX
$140M
| $4M | 0.01% |
884,272
-28,600
| -3% | -$129K |
|
1586
Pinnacle Financial Partners
PNFP
$7.55B
| $4M | 0.01% |
40,796
-15,500
| -28% | -$1.52M |
|
1587
Heron Therapeutics
HRTX
$193M
| $4M | 0.01% |
2,008,198
+14,398
| +0.7% | +$28.7K |
|
1588
Celsius Holdings
CELH
$14.9B
| $3.98M | 0.01% |
+127,000
| New | +$3.98M |
|
1589
Vanguard Emerging Markets Government Bond ETF
VWOB
$4.6B
| $3.98M | 0.01% |
+60,000
| New | +$3.98M |
|
1590
Consumer Portfolio Services
CPSS
$190M
| $3.97M | 0.01% |
423,758
-6,500
| -2% | -$61K |
|
1591
Astrana Health
ASTH
$1.38B
| $3.97M | 0.01% |
68,600
+19,400
| +39% | +$1.12M |
|
1592
GeneDx Holdings
WGS
$3.56B
| $3.97M | 0.01% |
93,573
+3,200
| +4% | +$136K |
|
1593
Alamo Group
ALG
$2.49B
| $3.96M | 0.01% |
22,000
-2,800
| -11% | -$504K |
|
1594
First Financial Corporation Common Stock
THFF
$691M
| $3.96M | 0.01% |
90,373
-37,418
| -29% | -$1.64M |
|
1595
Liberty Latin America Class A
LILA
$1.5B
| $3.96M | 0.01% |
413,200
-8,859
| -2% | -$84.9K |
|
1596
Eastern Company
EML
$155M
| $3.95M | 0.01% |
121,737
+1,200
| +1% | +$38.9K |
|
1597
Blend Labs
BLND
$1.12B
| $3.94M | 0.01% |
1,049,360
+395,700
| +61% | +$1.48M |
|
1598
A.O. Smith
AOS
$10.2B
| $3.93M | 0.01% |
43,800
-367,400
| -89% | -$33M |
|
1599
Cooper-Standard Automotive
CPS
$667M
| $3.92M | 0.01% |
282,900
+66,100
| +30% | +$917K |
|
1600
Talkspace
TALK
$429M
| $3.91M | 0.01% |
1,872,600
+411,600
| +28% | +$860K |
|